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AIM  
 
 
 
To compare visual outcome at one year following photorefractive 
keratectomy (PRK) and photorefractive keratectomy with mitomycin C in high 
myopia 
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INTRODUCTION 
 
 Myopia / short sightedness is a refractive error in which the parallel 
rays of light from infinity come to focus in front of the retina when the eye is at 
rest, thus grossly reducing the vision.  Myopia could be axial due to 
elongation of anteroposterior diameter of the eyeball or curvature myopia due 
to increase in radius of curvature of the cornea; and index myopia due to 
change in refractive index of lens, cornea, aqueous and vitreous, thus 
increasing the dioptric power of the eye.     
 
Photorefractive keratectomy (PRK)  
 Consists of the application of energy ofthe ultraviolet range generated 
by an argon fluoride (ArF) excimer laser to the anterior corneal stroma to 
change its curvature and, thus, to correct a refractive error. The physical 
process of remodeling the corneal stroma by ultraviolet (193 nm wavelength) 
high-energy photons is known as photoablation.  
History of the Procedure 
 During the 1980s, several applications of the 193-nm ArF excimer 
laser were investigated, including its use on human corneas for the correction 
of refractive errors. In 1988, Munnerlyn, Kroons, and Marshall reported an 
algorithm relating diameter and depth of the ablation to the required dioptric 
change.  
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 McDonald performed the first excimer PRK for the correction of myopia 
on a normally sighted human eye in the United States. That same year, the 
Food and Drug Administration (FDA) organized a 3-phase trial, the PRK study 
(which ended in 1996), to demonstrate the safety, predictability, and stability 
of PRK for the treatment of myopia. At the end of this trial, 2 ophthalmic 
companies, VISX and Summit, were allowed to manufacture excimer lasers 
for widespread use in the United States. Since then, Nidek also has obtained 
approval for the manufacture of excimer lasers in the United States, and 
several hundred thousand patients have undergone this procedure 
throughout the world. The first excimer lasers used to perform PRK in the late 
1980s have been improved significantly in terms of size, efficiency, and 
accuracy. 
Pathophysiology 
 The mechanism of ablation of the excimer laser appears to be 
photochemical in nature and is known as photochemical ablation or ablative 
photodecomposition. This highly localized tissue interaction is based on the 
fact that each photon produced by the ArF excimer laser has 6.4 eV of 
energy, enough to break covalent bonds.  
 The efficacy and success of PRK depends largely on the type of laser 
platform in use.  Current fifth generation systems use a very rapidly repetitive 
and extremely small spot delivery with automated tracking of the eye 
movements to ensure precise treatment. 
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 The intramolecular bonds of exposed organic macromolecules are 
broken when a large number of high-energy 193-nm photons are absorbed in 
a short time. The resulting fragments rapidly expand and are ejected from the 
exposed surface at supersonic velocities. This mechanism explains why only 
the irradiated organic materials are affected, whereas the adjacent areas are 
not affected.  
 The return of corneal innervation up to 5 years after PRK was 
measured. Corneal subbasal nerve density does not recover to near 
preoperative densities until 2 years after PRK, as compared to 5 years after 
laser in situ keratomileusis (LASIK). 
Mitomycin C   
   
Isolated from streptococcus calspitosus in 1958, mitomycin react with DNA in 
ways similar to alkylating agents. It cross links DNA and inhibits its synthesis. 
It is highly effective antimitotic agent used in treatment of carcinoma of 
stomach and colon.  The ocular indications for the mitomycin C are recurrent 
pterygium and glaucoma filtering surgery. 
Kulitoma and Mori (1976) reported favorably on the efficacy of mitomycin C 
eye drops in recurrent pterygium. 
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Use of mitomycin C in PRK 
 They act by inhibiting activated keratocytes, probably by interfering 
with DNA synthesis, which decreases cellular activity and reduces collagen 
synthesis. Mitomycin inhibits fibroblst function by a dose dependent inhibition 
of fibroblast proliferation.  
 Mujmudar et aladn Raviv et al reported mitomycin C efficacy in treating 
significant pre existing corneal scarring  
 
Corneal Anatomy 
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Cornea has five layers 
  Epithelium (30-50)mu 
 Bowmans Membrane (10-14)mu 
 Stroma (500-700mu) 
 Descemets Membrane (3-12) 
 Endothelium (4-6) 
The average corneal diameter is 11.5mm (vertical) and 12mm horizontal. 
1. Epithelium is stratified squamous and nonkeratinised and comprises  
 Single layer of columnar cells (basal) 
 2 to 3 round wing cells 
 2 layers of squamous surface cells 
 
2. Bowman layer is the acellular superficial layer of the stroma, which 
scars when damaged. 
3. The stroma makes up 90% of corneal thickness comprised of regularly 
oriented layers of collagen fibrils whose spacing is maintained by 
proteoglycan ground substance (chondroitin sulphate and keratin sulphate) 
with interspersed modified fibroblasts. 
4. Descemet’s membrane- fine latticework of collagen fibrils. 
5. Endothelium- single layer of hexagonal cells.  It plays a vital role in 
maintaining corneal deturgescence but does not regenerate. 
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REVIEW OF LITERATURE 
 
Myopia 
 Short sightedness is a type of refractive error in which parallel rays of 
light coming from infinity are focused in front of the retina when 
accommodation is at rest. 
 
 
 
 
Mechanism of production 
 
1. Axial myopia results from increase in anteroposterior length of the 
eyeball.  It is the commonest. 
2. Curvatural myopia occurs due to increased curvature of the cornea, 
lens, or both. 
3. Positional myopia- anterior placement of crystalline lens in the eye. 
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4. Index myopia- results increase in RI of crystalline lens associated with 
nuclear sclerosis. 
5. Myopia due to excessive accommodation occurs in patients with 
spasm of accommodation. 
 
Optics of Myopia  
In myopes, a near object may be focused without any effort of 
accommodation if it is situated at the punctum remotum.  The image of an 
object at infinity is made up of circles of diffusion formed by diverging beam.  
The nodal point in myopes is further away from the retina and image formed 
is larger in size.  Accomodation is of little value to myopes for higher errors.  
The amplitude of accommodation is small.   
Classification of Myopia 
a. Congenital Myopia 
b. Simple Myopia 
c. Pathological Myopia 
d. Acquired Myopia 
 
Congenital Myopia 
9 Is present since birth 
9 Diagnosed by the age of 2-3 years 
9 Seen in premature children or in various birth defects such as Marfan’s 
syndrome or Homocysteinuria 
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9 Is unilateral and manifests as anisometropia 
9 Error is about 8 to 10 D associated with congenital squint 
9 Associated with cataract, microphthalmos, aniridia, megalocornea and 
congenital separation of retina 
 
Simple Myopia 
 
Simple or developmental myopia is the commonest type and considered as a 
physiological error and not associated with any disease of the eye. 
 
Etiology:  It results from normal biological variations in development of the 
eye which may or may not be genetically determined. 
 
Axial Myopia:  results from the increase in the anteroposterior length of the 
eyeball.  It is the commonest form. 
 
Curvature Myopia:  results from increase in the radius of curvature of the 
cornea, lens or both.  A variation of 1 mm of radius of curvature results in a 
refractive change of 6 D. 
 
Index Myopia:  Here, changes in dioptric system may be due to change in 
refractive index of lens, cornea, aqueous or vitreous.  The dioptric power of 
the eye is too strong for the axial length of the eye. 
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Clinical Symptoms: 
9 Poor vision for distance (short sightedness) is the main symptom of 
myopia. 
9 Asthenopic symptoms occur in patients with small degree of myopia.  
Eyestrain develops due to dissociation between convergence and 
accommodation. 
9 Fusion becomes weak and binocular vision is affected. 
9 Patient starts suppressing one eye and suppressed eye deviates 
outwards. 
9 Decreased visual acuity in indoor activities. 
 
Signs: 
 
 The eye of simple myopia is large and prominent.  Chamber is deep 
and pupil reaction is sluggish.  Macula appears slightly nearer to disc.  There 
may be divergent squint. 
 
Pathological / Progressive / Degenerative Myopia 
 
 It is a rapidly progressive error resulting in high myopia during 
early adult life, usually associated with degenerative changes in 
the eye. 
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 It results from rapid axial growth of the eyeball outside the 
normal biological variation of development. 
 It is definitely linked to heredity and general growth process. 
 
Heredity factor:  Progressive myopia is familial and more common in races 
like the Chinese, Japanese, Arabs and Jews. 
 
Role of general growth process:  Factors like nutritional deficiency, debilitating 
diseases, endocrinal disturbances and indifferent general health also 
influence progress of myopia. 
 
Clinical Picture 
¾ Defective vision  
¾ Night blindness 
¾ Muscae volitantes 
 
Signs 
   Eyes are more prominent 
   Anterior Chamber is deep 
   Cornea appears large 
   Pupil slightly large and sluggish 
   Refractive error increases by as much as 4D yearly and usually 
stabilizes at the age of 20. 
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Fundus Picture 
 
o Optic disc appears large and pale 
o Myopic crescent 
o Atrophy of retinal pigment epithelium and choriocapillaries- tigroid 
appearance due to visible prominent large choroidal vessels 
o Atrophic patches at macula 
o Foster Fuchs spot 
o Cystoid degeneration 
o Posterior staphyloma 
o Posterior vitreous detatchment 
o Contraction of visual fields 
o ERG subnormal 
 
Complications 
 
¾ Retinal detachment 
¾ Complicated cataract 
¾ Vitreous haemorrhage 
¾ Choroidal haemorrhage 
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Treatment 
Non Surgical 
 
9 Spectacle correction with concave lens 
9 Contact lens 
 
Surgical 
9 Radial Keratotomy 
9 Photo-Refractive-Keratectomy 
9 LASIK 
9 Intra corneal ring implantation for low myopia 
9 Phakic IOLS  
 
History 
 
 Refractive surgery has been used to correct myopia and 
hypermetropia for more than 40 years.  Conceptually, refractive corneal 
surgery attempts to remove, add or modify the corneal stroma, so that the 
radius of curvature of the anterior corneal interface is altered as desired. 
 Based on the fundamental principle that cornea contributes twothirds 
of refracting power of the eye, Barraquer attempted to alter the tear film/ 
anterior cornea interface radius of curvature by adding or removing corneal 
tissue. 
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 Keratomileusis in situ- derived from the Greek word keras ( horn-
like=cornea) smileusis- carving. Keratomileusis in situ for myopia was the first 
to develop in late 1940.  The procedure involved raising a corneal flap and 
removing tissue from residual stromal bed.  Barraquer performed a free hand 
lamellar dissection of the anterior half of the cornea with a keratome.  
Subsequently, refractive cut was attempted with second pass of the knife to 
remove stromal bed and cap was replaced with flattening of corneal curvature 
thus reducing myopia.  This procedure was abandoned due to many technical 
difficulties. 
 The gateway to Keratophakia opened in 1961, which involved 
steepening of central corneal curvature by placing a disc of tissue under the 
lamellar cap derived from alloplastic stromal disc harvested from a donor 
cornea. 
 This was seen a possible solution in aphakia, but with advent of IOL, 
interest in keratophakia subsided.        
 
Freeze myopic Keratomileusis 
 
 In an effort to overcome technical difficulties of manual cut, Barraquer 
used contact lens lathe to sculpture the frozen lamellar cap. Barraquer 
recognized that the cutting speed and the relation between FOP and diameter 
of resection were factors directly affecting quality and depth of cut.  His efforts 
for more predictable and accurate cuts led to the development of applanator 
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lenses, suction rings of various diameters and various heights of 
microkeratome tracks.  This work constituted the basis of future 
microkeratome evolution. 
 
Disadvantages: 
1. Learning curve was too steep with higher complication rate. 
2. Cryolathe was too expensive and complex to maintain. 
 
Epikeratoplasty 
 
 Epikeratophakia was introduced in1979 by Kaufmann and Werblin to 
avoid use of cryolathe.  They used preprocessed refractive lenticules.  A 
stromal disc was removed from the donor eye with microkeratome and was 
frozen and lathed into concave or convex lenses and then lyophilized and 
stored for later use.  It was intended for use in myopia, hypermetropia and 
keratoconus. 
 
Complications 
 
1. Persistent epithelial defect 
2. Epithelial ingrowth 
3. Melting, scarring 
4. Epithelialisation of donor lenticule 
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Barraquer-Krumeich Swinger (BKS) technique 
  
 An improved microkeratome, a set of dyes and suction stand 
microkeratome was used to perform a total lamellar cap.  The cap was placed 
epithelial side down on suction rings for microkeratome to perform second cut 
on stromal aspect of cap.  The sculptured lamellar disc was finally sutured 
back to the bed.  The nonfreezing technique has more advantage over freeze 
techniques with rapid and comfortable recovery, preservation of fibroblasts 
and epithelium.  However, significant astigmatism could not be avoided. 
 
Automated lamellar keratoplasty 
  
 Development of automated geared microtome by Ruiz in 1980 
introduced Automated lamellar keratoplasty.  Speed of the cut could be 
controlled resulting in more even and consistent cuts. 
 The second cut was made on the bed.  The depth of second cut was 
adjusted by altering the height of suction ring and corneal cap was sutured 
back. 
 
Advantages 
9 Rapid recovery 
9 Efficacy in correcting high myopia 
9 Ease of use 
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Disadvantages 
 
¾ High degree of irregular astigmatism 
 
Photorefractive Keratectomy 
  
 It is a procedure of photoablation by Excimer laser which has been in 
use for the treatment of myopia, hypermetropia and astigmatism. 
  
 Photorefractive keratectomy has gained maximum success in myopic 
patients. Photorefractive keratectomy has become popular after Srinivasan, 
Barren and Trokel in 1983 thought that excimer laser can be used to cut the 
cornea. 
 Photorefractive keratectomy gives good results from –2 to –6 D of 
myopia. 
 
Indications 
1. Superficial scar with myopia 
2. Basement membrane dystrophy with myopia 
3. myopia when unable to use a microkeratome because of high brow or 
tight lid with narrow palpebral fissures 
4. Glaucoma suspects 
5. cornea thinner than 500 microns 
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 Photorefractive keratectomy can be satisfactorily performed under 
topical anesthesia.  The center of the pupil is marked; the epithelium is 
removed by mechanical debridement with a blunt hockey knife followed by 
followed by ablation of corneal stroma with excimer laser.  Reepithelialisation 
occurs in 3 to 4 days.  Improvements in the laser profile, small spot size, 
flying spot technology and Gaussian curve in conjunction with mitomycin C 
have made it possible to treat higher degrees of myopia.  Epithelium can also 
be removed using alcohol or by excimer laser. 
  
Complications are Uncommon Which Include 
 
1. Corneal haze and regression 
2. Night glare and halos 
3. Delayed epithelial healing 
4. Corneal ulceration 
5. Corneal infiltration 
6. Central islands 
7. Decentration of ablation zone 
 
Lasik 
 Is a keratorefractive surgery that combines the precision of excimer 
laser photoablation with advantages of an intrastromal procedure that 
maintains the integrity of Bowmans layer and overlying epithelium.  It was 
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introduced, designed and developed at University of Crete and Verdin 
Oyannion Eye Institute of Crete in 1988. 
 Currently, this procedure is being considered the refractive surgery of 
choice for myopia because of its definite advantages over PRK and RK.  
LASIK can be used to correct upto –15D of myopia and upto –6D of 
astigmatism depending on the excimer laser platform used. 
 Mel 80 excimer laser is approved by the FDA for correction of myopia 
upto -7.00 D. It can be used for correcting errors upto -15.00D, but it is a “off 
label” use. 
 
Preoperative evaluation 
 
 Marguente Mc Donald MD of New Orleans, Louisiana performed the 
first PRK and has been one of the key surgeons responsible for extensive 
pioneering work in appropriate approach to PRK.   
A thorough preoperative evaluation is of critical importance in 
achieving a successful outcome following refractive surgery.  During this 
evaluation, the surgeon decides if the patient is or not a good candidate for 
refractive surgery. 
 
1. MEDICAL HISTORY:  It should include history of any systemic disease 
like diabetes, prior surgeries, connective tissue disorders, and any 
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immunocompromised states like HIV / AIDS, drug history - isotretinold, 
somatripten, amiadarone, and hormone replacement therapy. 
 
2. REALISTIC PATIENT EXPECTATION:  The ophthalmologist should 
explain in detail about the refractive results.  Patients should 
understand will not prevent possible future ocular problems like 
cataract, glaucoma or retinal detachment.  Patients should be told that 
PRK is being done to decrease dependence on glasses and not to get 
rid of glasses. 
 
3. Patient ocular history, blepharitis, recurrent erosion, dry eyes, retinal 
tears, detachment, use of glasses, stability of current refraction, 
contact lens history- types of contact lens, duration of contact lens use.  
Patient should discontinue soft contact lens for at least three days to 
two weeks prior to surgery.  After 40 years, patients who have 
undergone refractive surgery will need presbyopic correction with 
glasses and this should be explained to the patient. 
 
4. Uncorrected visual acuity for distance and near should be measured to 
determine the amount of correction to be performed.  Full cycloplegic 
refraction is mandatory.  A final subjective refraction using the 
autorefractometer, Wasca aberrometer values and cycloplegic 
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refraction should be done by the ophthalmologist and refined using 
duochrome test.    
 
Pupil size 
 Pupillary examination involves evaluating pupil size in bright room light 
and dim illumination, any afferent papillary defect, various techniques to 
measure the size of the pupil like light amplification pupillometer, infrared 
pupillometer, Wasca aberrometer. 
 Large pupil may be one of the risk factors for postoperative glare and 
halo after refractive surgery.  Optical zone should be larger than pupil 
diameter to prevent glare and haloes.   
 
Ocular motility or confrontation fields 
 Asymptomatic tropia and phoria may develop symptoms after surgery 
if change of refraction causes the motility status to break down.  Orthoptic 
evaluation should be done preoperatively.  Confrontation fields should be 
done in all patients. 
 
Intraocular pressure 
 In patients with glaucoma, lasik elevates the IOP during the procedure, 
aggravating optic nerve damage.   
 Topical corticosteroid use after PRK may cause elevation of IOP in 
corticosteroid responders. 
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Slit lamp Examination 
 Complete slit lamp examination of eye, lids, cornea and anterior 
segment should be performed to check for meibonitis, stye, blepharitis, tear 
film stability, conjunctival scarring, pterygium, epithelial erosions, dystrophies, 
keratoconus or any opacities. 
 Depth of anterior chamber and lens clarity should be assessed. 
 
Detailed Fundus Examination 
  It is important to be certain that the posterior segment is normal.  
Special attention is given to the optic nerve (glaucoma, optic nerve drusen), 
peripheral retina (retinal tear, detachment, retinal holes, peripheral 
degeneration, high myopia) are at increased risk for retinal detachment. 
  
Corneal Topography 
  It should be done to rule out keratoconus, contact lens     
warpage   
  
Ultra sound Pachymetry 
  It is done for central corneal thickness. 
  
Wavefront analysis 
  This is done by using wasca aberrometer.. 
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Informed consent 
 After evaluation, the surgeon analyses all the information and 
discusses the possibilities with the patient.  Risks and benefits of various 
medical and surgical alternatives are discussed. 
 
Discussions with the patient should include 
1) Expected uncorrected visual acuity 
2) Risk of decreased BCVA, severe visual loss, glare haloes, dry eyes 
3) Need of distant or reading glasses 
4) Patient should be given informed consent documents and should sign 
the form well before the surgery. 
 
PROCEDURE 
 In this technique to correct myopia, a central optical zone of anterior 
corneal stroma is photoablated using Excimer Laser to cause flattening of 
central cornea. 
Surgical steps are:- 
 
1. ANAESTHESIA: PRK can be satisfactorily performed under topical 
anaesthesia. 
2. EPITHELIUM REMOVAL: Deepithelialisation methods include 
mechanical debridement with blunt blade under topical anaesthesia.  
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Other deepithelialisation methods include alcohol and photoablative 
deepithelialisation.  Attempt should be made to deepithelialise 0.5mm 
to 1mm larger area than the desired ablative zone. The time lapsed 
from the removal of corneal epithelium to the application of laser 
energy should be minimized to prevent extreme drying or wetting of 
corneal surface.  Always avoid leaving any residual islands of 
epithelium. 
3. ABLATION ZONE DIAMETER:  small ablative zones are known to 
cause symptomatic haloes while night driving.  Increasing experience 
in PRK has shown that the ideal diameter of ablation zone for myopia 
is 6mm and for hypermetropia is 9mm. 
4. FIXATION AND CENTRATION OF THE ABLATION ZONE:  some 
surgeons use hand held suction rings, while others promote the 
method of self fixation by the patient during ablation.  Fixation light on 
the microscope should be co axial with surgeon’s and patient’s line of 
vision. 
5. Co-axiality of fixation light should be maintained with the laser light 
also. It should always be explained to the patient that the clarity of 
fixation target will decline during ablation, but will be visible and that he 
should try to fix it.  It is always better to patch the fellow eye to prevent 
cross fixation.  Laser beam should be aimed at the center of the pupil. 
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6. FLUENCE AND REPETITION RATE:  Changes in fluence and 
repetition rate affect not only the rate at which tissue is removed and 
the operation time, but also the surface morphology of the ablated 
corneal tissue. 
7. SCANNING LASER BEAM:  The laser device can be smaller and 
cheaper if small diameter circular or narrow slit beam is used for 
scanning the ablated area. 
8. ASPHERIC ABLATIONS:  This is a unique advantage of PRK.  
Planned aspheric ablations are made in high myopia, which avoid 
central islands, thereby decreasing postoperative spherical 
aberrations.  Astigmatism occurring due to naturally,  post traumatic, 
post infective and post surgical correction is done by ablating the 
superficial cornea in a cylindrical fashion known as toric photoablation. 
 
              The laser is centered and focused according to the manufacturer’s 
recommendations.  Although the excimer laser beam, a 193nm, is invisible to 
the human eye, a faint fluorescence of deep blue light is sometimes visible 
during stromal ablation. 
 
 The sound of the laser firing is the main feedback signal to the surgeon 
along with an alteration in light reflex as the stromal ablation progresses. 
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 In order to attempt to decrease the chance of postoperative corneal 
haze after PRK in high myopia, a soaked pledget usually 0.2mg/ml mitomycin 
can be placed on the ablated surface for 30 seconds to two minutes at the 
end of laser exposure.  The cornea is then irrigated with balanced salt 
solution to remove excess mitomycin to avoid damage to limbal stem cells. 
 
Immediate post ablation methods: 
 
 After the procedure is completed, a single drop of antibiotic and NSAID 
are placed in the eye after a bandage soft contact lens is inserted. 
 
Subsequent postoperative care: 
 The patient should be followed closely until the epithelium is 
completely healed, which usually occurs within 72 hrs.  As long as the 
bandagesoft contact lens is in place, patients are treated with topical broad 
spectrum antibiotics and corticosteroids, usually 4 times a day. 
 
 Studies have shown that corticosteroids are effective in limiting haze 
and myopic regression after PRK, particularly after higher myopic corrections 
when used after bandage soft lens removal.  Corticosteroid drops are tapered 
over 3 to 4 months depending on the corneal haze and refractive outcome.  
Artificial tears are used frequently. 
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EVOLVING TECHNOLOGY: 
 
 As the early broad beam Excimer laser systems improved and as 
surgeon experience increased, PRK results improved markedly.  The ablation 
zone diameter enlarged because small ablation zones, originally selected to 
limit depth of tissue removal, produced more haze and regression as well as 
glare and haloes.  The larger treatment diameter used today includes optical 
zones and aspheric peripheral bald zones improve both optical quality and 
refractive stability in myopia and hyperopic treatments. 
 
 Central island elevation has become less common with improvement in 
beam quality and with development of scanning excimer lasers. 
 
TRACKING DEVICES:   
Two types of tracker technology exist: 
a. Closed loop:  High speed oscillating infrared beams scan across the 
edge of fixed dilated pupil.  The beams detect the abrupt change in 
reflected light at the edge of the pupil.  This signal then directs rapidly 
responding mirrors to create a space-stabilised image and the laser 
beam is located on the cornea on next image. 
b. Open loop:  Uses video to monitor the location of an infrared image of 
the pupil and to shift the laser beam accordingly. 
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COMPLICATIONS: 
1) OVERCORRECTION:  of more than +1.0D at one year occurs in less than 
5% of myopes.  Myopic or hyperopic PRK undergoes regression for at 
least 3 to 6 months.  Refractive stability must be achieved before deciding 
whether overcorrection requires retreatment. 
2) UNDERCORRECTION:  occurs much more frequently at higher degree of 
myopia because of decreased predictability resulting from the greater 
frequency and severity of regression.  Regression is markedly increased 
with optical zones of less than 6mm diameter. 
3) CENTRAL ISLANDS:  Kreuger RR, McDonnell PJ clinical analysis of 
steep central islands after excimer laser PRK Arch Ophthalmol 1996 
114.377-381 with computer assisted topographic analysis.  Corneas show 
a central region of higher corneal refractive power compared to adjacent 
paracentral cornea.  These are the causes of undercorrection, asphericity 
and irregular astigmatism. Many theories have been put forward to explain 
their formation.  These include: 
a) Shock wave formation and ejection of plume of gaseous and 
particulate debris, which interfere with subsequent proper 
delivery of laser. 
b) Undesired optics of the laser or variation in beam homogeneity. 
c) Differential hydration of the corneal tissue postoperatively. 
d) Healing being non-uniform leads to greater epithelial 
hyperplasia centrally. 
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4) DECENTRATION OF THE ABLATION ZONE:  Usually occurs either due 
to poor alignment with patient fixation or due to eye movements during 
surgery.  These patients experience degeneration of optical performance.  
Diplopia, glare haloes and induced astigmatism with loss of BCVA are the 
problems associated with decentration.  
 Layer decentrations may cause complaints of glare, haloes and 
decreased visual acuity.  The patient may experience more symptoms if the 
decentration zone is more than 1.0mm.  Patients with larger pupil may 
experience symptoms with smaller amounts of decentration, because the 
edge of the decentered ablation will more easily be perceived within the 
patient’s visual axis.  It can be prevented by proper stabilization of the 
patient’s head and by alertness of the surgeon in stopping the ablation if the 
patient begins to lose fixation. 
 
5) OPTICAL ABERRATIONS:  Some patients report optical aberrations 
including glare, ghost images and haloes.  These symptoms are more 
prevalent after treatment with smaller ablation zones and after higher 
attempted correction.  These complaints seem to be exacerbated at night 
and are more prevalent in young myopic patients with large pupillary 
diameters due to an optical zone that is smaller than entrance pupil under 
conditions of dim illumination.  This problem can be treated with second 
ablation by increasing diameter to 6mm. 
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6) CORNEAL HAZE:  Wound healing patterns after PRK can be separated 
into three groups.   
i) Normal healers who have trace to 1+ haze and a refraction of 0 to 
1.0D at 1 month. 
ii) Inadequate healers who have no haze and a refraction >+1.0D 
beyond the target correction at 1 month. 
iii) Aggressive healers, whose have 1+ or greater haze that increases 
in month 2 and 3 accompanied by regression of the correction. 
iv) Subepithelial corneal haze typically appears several weeks after 
PRK, peaks in intensity at 1 to 2 months and gradually disappears 
during the following 6 to 12 months. 
v) Late onset corneal haze that occurs several months or even 1 year 
or more postoperatively after a prior period of relatively clear 
cornea. 
vi) Histologic studies in animals with cornea haze after PRK 
demonstrate abnormal glycosaminoglycans and or nonlamellar 
collagen deposited in anterior stroma as a consequence of 
epithelial-stromal wound healing. 
vii) Topical steroids are useful in resolving the level of haze as well as 
any refractive regression due to haze.  Excimer laser retreatment 
may be required in cases where have persists beyond 6 months 
and is associated with regression. 
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7) DELAYED EPITHELIAL HEALING:  Keratoconjuctivitis sicca, topical anti-
inflammatory drugs, prophylactic antibiotic therapy and bigger debrided 
area are the commonly known causes for delayed epithelial healing. 
8) RECURRENT EPITHELIAL EROSIONS:  There are known to occur if 
epithelial defect made before ablation procedure is larger than the ablation 
zone. 
9) CORNEAL INFILTRATION:  The sterile corneal infiltrates are usually focal 
but may be multicentric.  These appear days to weeks after surgery.  It 
they are central they may cause reduction in visual acuity. 
10) CORNEAL ULCERATION:  Patients getting bandage soft contact lens 
after PRK are prone for corneal ulcers. 
11) DECREASED CORNEAL SENSATIONS:  patient with high myopia 
undergoing larger and deeper ablations show reduced sensitivity more 
than other. 
12) CORTICOSTEROID INDUCED COMPLICATION: Raised IOP is thought 
to be due to postoperative topical corticosteroids.  Corticosteroid induced 
glaucoma occurs in 1.5% to 3% of patients using fluoromethasone.  25% 
of patient using dexamethasone. Other complications that have been 
reported after PRK are corticosteroid induced induced herpes simple virus 
keratitis, corticosteroid induced ptosis and corticosteroid induced cataract. 
 
13) DRY EYE:  condition occurs after PRK as a result of denervation with less 
severity and denervation. 
 38
Research Review 
 Bedei et al (2009) reported in a prospective, consecutive, 
observational study of 124 eyes of 62 patients were divided into two groups of 
31 patients, 62 eyes each (Groups A and B). Only Group A was treated with 
MMC 0.02%. The data of the two groups of eyes, related to the best-
corrected visual acuity (BCVA), to the difference of refraction pre- and post-
treatment, and to the corneal haze, were analyzed through combined 
permutation tests by using the NPC Test software. 
 
 Bedei et al concluded the application of MMC 0.02% solution 
immediately after PRK produced lower haze rates and had better 
predictability and improved efficacy 1 year after treatment. 
 
 Gambato et al (2004) studied the role of topical mitomycin C in corneal 
wound healing (CWH) after photorefractive keratectomy (PRK) in highly 
myopic eyes .A prospective, double-masked, randomized clinical trial. 
Seventy-two eyes of 36 patients affected by high (>7 diopters) myopia. At 1 
year, corneal haze developed in 20% of corticosteroid-treated eyes, versus 
0% of mitomycin C-treated eyes. At 12, 24, and 36 months, corneal confocal 
microscopy showed activated keratocytes and extracellular matrix 
significantly more evident in untreated eyes (Ps = 0.004, 0.024, and 0.046, 
respectively).  
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 Gambato et al concluded that topical intraoperative application of 
0.02% mitomycin C can reduce haze formation in highly myopic eyes 
undergoing PRK. 
 
 Hashemi et al (2003) studied the effect of prophylactic application of 
mitomycin-C on haze formation in photorefractive keratectomy (PRK) for high 
myopia. 54 eyes of 28 myopic patients were enrolled in this prospective 
study. All eyes were operated by PRK followed by 0.02% mitomycin-C 
application for two minutes and washed with 20 ml normal saline afterwards. 
All eyes were examined thoroughly on the first 7 days and one month after 
surgery; 48 eyes (88.9%) at 3 and 6 months postoperatively. Hanna grading 
(in the scale of 0 to 4+) was used for assessment of corneal haze.  
 
 Hashemi et al (2003) concluded the efficacy of mitomycin-C in 
preventing corneal haze after treatment of high myopia with PRK. This 
method- PRK + mitomycin-C - can be considered an alternative treatment for 
myopic patients whose corneal thickness is inadequate for laser in situ 
keratomileusis (LASIK).  
 
 Carones et al (2002) studied the prophylactic use of mitomycin-C to 
inhibit haze formation after excimer laser photorefractive keratectomy (PRK) 
for medium and high myopia in eyes that were not good candidates for laser 
 40
in situ keratomileusis (LASIK). This prospective randomized masked study 
comprised 60 consecutive eyes (60 patients). The inclusion criteria were a 
spherical equivalent correction between -6.00 and -10.00 diopters (D) and 
inadequate corneal thickness to allow a LASIK procedure with a residual 
stromal thickness of more than 250 microns. 
 
 Carones et al concluded prophylactic use of a diluted mitomycin-C 
0.02% solution applied intraoperatively in a single dose after PRK produced 
lower corneal haze rates, better UCVA and BCVA results, and more accurate 
refractive outcomes than those achieved in the control group. 
 
 Nassaralla et al (2007) studied the efficacy and safety of mitomycin C 
(MMC) 0.02% in inhibiting haze formation after excimer laser photorefractive 
keratectomy (PRK) for residual myopia following radial keratotomy (RK).  A 
prospective, nonrandomized, noncomparative interventional case series was 
conducted of 22 eyes (14 patients) with residual myopia after RK. 
 
  Nassaralla et al concluded a single intraoperative application of MMC 
0.02% for 2 minutes appears to be effective in preventing subepithelial haze 
after PRK for residual myopia in patients with undercorrection or regression 
following RK. 
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 Srinivasan et al (2008) reported the efficacy and safety of prophylactic 
mitomycin C (MMC) during photorefractive keratectomy (PRK) over LASIK 
flaps for the treatment of residual refractive errors following LASIK. In this 
single center, retrospective clinical study, 30 eyes of 33 patients (mean age 
37.2 years) who had MMC (0.02%, 30 to 120 seconds) during PRK for the 
treatment of residual refractive errors following myopic LASIK were evaluated.  
 
 Srinivasan et al concluded photorefractive keratectomy with 
prophylactic MMC (0.02%) is a safe and effective option for treating myopic 
regression following LASIK. A single intraoperative application of 0.02% MMC 
for as few as 30 seconds was effective in preventing postoperative haze 
formation. 
 
 Wallau  and Campos (2008) studied 88 eyes of 44 patients with a 
minimum estimated ablation depth of 50 microns were randomized to receive 
PRK with MMC 0.002% for 1 minute in one eye and LASIK in the fellow eye 
to compare photorefractive keratectomy (PRK) with prophylactic use of 
mitomycin C (MMC) and LASIK in custom surgeries for myopic astigmatism. 
He concluded photorefractive keratectomy with MMC appears to be more 
effective than LASIK in custom surgery for moderate myopia. During 6-month 
follow-up, no toxic effects of MMC were evident.  
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 Shojaei A, Mohammad-Rabei H, Eslani M, Elahi B, Noorizadeh 
F.reported long-term evaluation of complications and results of 
photorefractive keratectomy in myopia: an 8-year follow-up. Cornea. 2009 
Apr; 28 (3):304-10.   
 
 Shojaei et al (2009) evaluated 8-year results of photorefractive 
keratectomy (PRK) for myopia in terms of safety, efficacy, stability, and late 
complications. From 371 myopic eyes of 203 patients, who underwent PRK 
using NIDEK EC-5000 excimer laser with 5.5- to 6-mm ablation zones in 
Basir Eye Center, Tehran, Iran,  
 
 Shojaei et al concluded PRK seems to be a safe, efficient, and stable 
surgical procedure, and if patients obtain a good result with the initial 
treatment, then their results are relatively stable over time. 
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      MATERIALS AND METHODS 
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PATIENTS AND METHODS 
Patients with high  myopia (-6D to –16D) undergoing PRK and PRK with 
mitomycin C using the Mel80 Excimer system at the cornea clinic, Institute of 
Ophthalmology, Joseph Eye Hospital, Trichy, between September 2008 and 
September 2009. 
 
Design  
Prospective, comparative, randomized study 
 
Inclusion criteria 
 
 Superficial scar with myopia 
 Basement membrane dystrophy with myopia 
 Myopia when unable to use a microkeratome because of high brow or 
tight lid    with narrow palpebral fissure 
 Cornea thinner than 500 microns 
 Glaucoma suspects 
 
Exclusion criteria 
 Cataract 
 Immunocompromised patients (poor healing, increased risk of 
infection) 
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 Strabismus 
 Retinal detatchment 
 A standard protocol was used to collect and document all the details 
regarding the cases included in the study. 
 Detailed information about history, complaints, occupation of the 
patient was taken.  This included type of visual problem, duration of 
symptoms, duration of wearing glasses/ contact lens, frequency of changing 
glasses, any prior corneal surgery, trauma, any prolonged use of topical 
medications and any history of systemic disease.  
 
 A complete ocular examination was done for each patient which 
included uncorrected visual acuity, best corrected visual acuity following 
cycloplegic refraction, slit lamp examination, corneal topography, ultrasound 
pachymetry, pupillary size, non contact tonometry, slit lamp biomicroscopy 
with a +90D, indirect ophthalmoscopy and Wasca aberrometer. 
 
 Antibiotic drops (Ofloxacin/ Gatifloxacin) 4 times a day prescribed 1 
day before surgery. 
 Patient was advised not to use deodorants, perfumes, flowers on the 
day of surgery to avoid attenuation of laser energy. 
 Patient was asked to wash face with soap and water 
 Ofloxacin eye drops and NSAID eye drops applied 3 times at 15 min. 
intervals 
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 One drop of  proparacaine applied 20 min. before scheduled surgery 
 Patient was positioned on the laser bed and one more drop of 
proparacaine applied 
 Eyelid margins were prepared with betadine (0.5%) 
 Head was draped with towel and speculum applied 
 Deepithelialisation was done with blunt hockey knife under topical 
anaesthesia 
 0.5 to 1.0 mm larger area than desired ablative zone was 
deepithelialised 
 Hand held suction rings were used to fix during ablation 
 Fixation light on the microscope was coaxial with surgeon’s and 
patient’s line of vision 
 The fellow eye was fixed to prevent cross fixation 
 Laser beam was aimed at the center of the pupil 
 In Mel80 excimer laser, the operating assistant (TOPASS) displays the 
progress of laser ablation 
 After PRK, a soaked pledget with 0.2mg/ml of mitomycin was placed 
on the ablated surface for 12 seconds at the end of laser procedure 
 The cornea is then irrigated with BSS to remove excess mitomycin to 
avoid damage to limbal stem cells 
 After the procedure is completed, a drop of antibiotic and NSAID is 
instilled and bandage contact lens is placed 
 Patient is followed closely until the epithelium is healed in 72 hrs 
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 As long as the bandage contact lens is in place, patients are treated 
with topical broad spectrum antibiotics and NSAIDs usually 4 times a 
day 
 Patients are discharged after removal of the bandage contact lens, 
after 3 days 
 The patient was asked to come for follow up on day one, day 3, 
1month, 3 months, 6months, and 1 year, when a thorough slit lamp 
examination was done and visual acuity and refraction recorded.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 48
        First Day Post Operative Picture 
 
 
 
Three Months Post Operative Picture 
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Wasca Aberrometer  
 
 
Mel 8O Excimer Laser  
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Corneal Pachymetry 
 
 
Corneal Topography 
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RESULTS 
In this prospective randomized study 29 eyes were allocated to group 1 and 
30 eyes to group 2.  
 Mean refractive error in group 1 was -9.08 ± 2.86 D 
 Mean refractive error in group 2 was -9.50 ±2.73 D’ 
 p value = 0.57 (statistically not significant) 
Group 1 underwent PRK and group 2 underwent PRK with mitomycin C.  
Patient demographics, age and gender, are indicated in Tables 1-3 and 
figures 1-3 
 
Table 1 Age distribution 
 
 
Age range Group 1 Group 2 
18 to 20 1 2 
21 to 25 8 7 
26 to 30 3 5 
31 to 35 3 1 
 
 
Figure 1 
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Table 2 
 
Sex distribution in group 1 
 
 
 
 
 
S.NO Sex No. of Patients 
1 Male  7 
2 Female 8 
 
 
 
 
 
 
Figure 2 
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Table 3 
 
Sex distribution group 2 
 
 
 
 
S.NO Sex No. of Patients 
1 Male  5 
2 Female 10 
 
 
 Figure 3 
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As shown below in Table-4, 
 After treatment, 15 eyes in each of the groups had UCVA of more than 
6/9 (p value=0.018). 8 eyes of group 1 and 9 eyes of group 2 had UCVA of 
6/12 to 6/9 (p value=0.042). 5 eyes of group 1 and 4 eyes of group 2 had 
UCVA of 6/24 to 6/18 (p value=0.174). 1 eye of group 1 and 2 eyes of group 2 
had UCVA of 6/60 to 6/36 (p value=0.357). 
 
Table 4 
 
Post treatment UCVA 
 
 
Visual Acuity Post PRK Post PRK with 
MMC 
Pvalue  
6/60 to 6/36 1 2 0.357 
6/24 to 6/18 5 4 0.174 
6/12 to 6/9 8 9 0.042 
>6/9 15 15 0.018 
 
 
Figure 4 
1
2
5
4
8
9
15 15
0
2
4
6
8
10
12
14
16
N
um
be
r 
of
 p
at
ie
nt
s
6/60 to 6/36 6/24 to 6/18 6/12 to 6/9 >6/9
Comparision of UCVA in Post PRK and Post PRK 
with MMC
Post PRK Post PRK with MMC
 
 
 56
 
As shown in Table-5, 
 18 eyes in group 1and 25 eyes in group 2 had BCVA of more than 6/9 
(p value=3.374), 8 eyes of group 1 and 4 eyes of group 2 had BCVA of 6/12 
to 6/9 (p value=1.849), 3 eyes of group 1 and 1 eye of group 2 had BCVA of 
6/24 to 6/18 (p value=1.147), None of the eyes of both groups had BCVA of  
less than 6/36 . 
Table 5 
Post treatment BCVA 
 
Visual acuity Group 1 Group 2 
6/60 to 6/36 0 0 
6/24 to 6/18 3 1 
6/12 to 6/9 8 4 
>6/9 18 25 
 
 
Figure 5 
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 As seen in Tables 4 & 5 and figures 4 & 5 , on comparing the visual 
acuity, it was found that final visual outcome in EACH of the groups was not 
statistically significant , p value>0.05. 
 Complications noted are as shown in the table 6 below 
 
Table 6 
 
Post Treatment Complications 
 
Complications        Group 1 Group 2 
Myopic 
Regression             10 10 
Corneal Haze             12 11 
Complicated 
Cataract              2 0 
Transient 
Glaucoma              0 2 
 
 
Myopic Regression: 
 Mean myopic regression in Group 1 at the final follow-up of one year 
was -2.175 D. 
 Mean myopic regression in Group 2 at the final follow-up of one year 
was -3.125 D. 
There was no significant statistical difference between the two groups for 
myopic regression. p value=0.26. 
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Corneal Haze: 
Corneal Haze was noted in 12 eyes in Group 1 and in 11 eyes in Group 2. 
There was no significant statistical difference between the two groups for 
corneal haze, p value=0.73. 
 
Complicated Cataract: 
Posterior subcapsular cataract was noted in 2 eyes in Group 1 for which 
cataract surgery was advised. 
 
Transient Glaucoma: 
Transient Glaucoma was noted in 2 eyes in Group 2, which was controlled by 
withholding steroids and instituting anti-glaucoma therapy. 
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DISCUSSION  
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Discussion 
 
 In this study, the mean spherical equivalent refraction in Group 1 was -
9.08 ±2.86 D and in group 2 was -9.505±2.73 D preoperatively.  
 At one year, out of 29 eyes in Group 1, in 15 eyes, an UCVA of  6/9 or 
better was achieved. In the same group, in 18 eyes, BCVA of 6/9 or better 
was achieved. 
 At one year, out of 30 eyes in group 2, in 15 eyes, an UCVA of  6/9 or 
better was achieved. In the same group, in 25 eyes, BCVA of 6/9 or better 
was achieved. 
 Corneal haze was noticed at first month follow-up in 12 eyes in group 1 
and 11 eyes in group 2. It remained the same at one year. Myopic regression 
was seen in 10 eyes in each of the groups. 
 In a similar study, Hashemi et al (2004) the mean spherical equivalent 
refraction (SE) was -7.08 diopters (D) +/- 1.11 (SD) preoperatively. Six 
months after surgery, 37 eyes (77.1%) achieved an uncorrected visual acuity 
(UCVA) of 20/20 or better, all eyes had a UCVA of 20/40 or better and 45 
(93.7%) eyes had an SE within +/- 1.00D. One month postoperatively, 2 eyes 
(3.7%) had grade 0.5+ of haze, while at 3 and 6 months after surgery no 
visited eye had haze at all. All eyes had a best corrected visual acuity (BCVA) 
of 20/40 or better and there were no lost lines in BCVA by 6 months after 
surgery. In spatial frequencies of 6 and 12 cycles per degree contrast 
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sensitivity had decreased immediately after PRK and it had increased 1.5 
lines by the 6th postoperative month compared to the preoperative data.  
 In another study, Carones et al (2002), No toxic or side effects were 
encountered postoperatively. No study group eye had a haze rate higher than 
1 during the 6-month follow-up; 19 eyes (63%) in the control group did (P 
=.01). At 6 months, the between-group difference in the refractive outcome 
was statistically significant (P =.05), with 26 study group eyes (87%) and 14 
control eyes (47%) within +/-0.50 D of the attempted correction. No study 
group eye had a BCVA loss during the follow-up; 7 control eyes had lost 1 to 
3 lines at 6 months (P =.0006).  
 Nassaralla et al (2007) described results at twelve months 
postoperatively, 3 eyes showed grade 1 haze, and 2 eyes showed grade 0.5 
haze. Twelve months postoperatively, 2 (9%) eyes had UCVA > or = 20/20. 
No eye before and 17 (77%) eyes after treatment had UCVA > or = 20/40, 
and no eye before and 9 eyes (40.9%) after treatment had UCVA > or = 
20/25. Best spectacle-corrected visual acuity was > or = 20/40 in all (100%) 
eyes and 21 (95%) eyes before and after treatment, respectively, and > or = 
20/25 in 12 (54.5%) eyes before and after treatment. One (4.5%) eye lost 1 
line of BSCVA. Mean spherical equivalent refraction achieved was -0.18 
diopters (D) (range: -0.75 to +0.50 D) compared to -2.72 D (range: -1.50 to -
4.00 D) before treatment. Twelve months after treatment, 19 (85.5%) eyes 
had a refractive outcome within +/- 0.50 D.  
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 Wallau  and Campos (2008) described Mean spherical equivalent 
refraction error before surgery and mean ablation depth were -3.99+/-1.20 
diopters (D) and 73.09+/-14.55 microm in LASIK eyes, and -3.85+/-1.12 D 
and 70.7+/-14.07 microm in PRK with MMC eyes, respectively. Uncorrected 
visual acuity was significantly better in PRK with MMC eyes 3 months (P=.04) 
and 6 months (P=.01) after surgery. Best spectacle-corrected visual acuity 
and spherical equivalent refraction did not differ significantly in the groups 
during follow-up (P>.05). Significant haze was not observed in any PRK with 
MMC eye. Mean higher order aberration was lower in PRK with MMC eyes 
postoperatively compared with LASIK eyes (P=.01). Better contrast sensitivity 
was observed in PRK with MMC eyes than LASIK eyes (P<.05). The 
endothelial cell count did not differ significantly between groups (P=.65). In 
terms of visual satisfaction, PRK with MMC eyes were better rated. 
 
 Shojaei et al (2009) described follow-up at 8 years after PRK, 69.64%, 
44.44%, and 45.65% of the low, moderate, and high myopic groups were 
within +/-0.5 D of emmetropia. Sixteen eyes (4.31% of original cases) 
underwent retreatment mainly because of regression. Although a small 
myopic shift occurred up to 8 years after surgery, changes in myopic 
regression stabilized in all myopic groups within 24 months. Four eyes 
(2.06%) lost 2 lines of best spectacle-corrected visual acuity (1 eye for 
corneal haze and other 3 for problems not related to refractive surgery). 
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 Corneal haze occurred in 11.34% especially in medium and high 
myopic groups, but it cleared within 2 years in 68.2% of cases. 
 Contrary to most studies in literature, viz., Bedei et al,2009; Srinivasan 
et al,2008; Wallau et al 2008;Hasan Hashemi,2004; gamboto et al, 
2004;Carones et al,2002 and others, in this study it was found that addition of 
Mitomycin C following PRK did not significantly decrease the incidence of the 
complications, corneal haze and myopic regression, as  indicated by the p 
value. 
 However, most studies advocating the use of  mitomycin C have used 
it for longer periods on the cornea, viz, 30secs(Srinivasan et al 2008), 
1minute ( Wallau et al 2008), 2minutes(Hasan Hashemi,2004).  
 A possible limitation in this study is that the 0.02% mitomycin C that 
was used was applied on the cornea for 12 seconds, as suggested by           . 
It is possible that application for longer durations could yield better results. 
Also, it remains to be seen if follow-up of the given cases for longer periods 
could show a difference in the incidence of complications between the two 
groups. 
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Conclusion 
 
              Following PRK and PRK with mitomycin C in high myopia, no 
difference in the visual outcome was statistically discernable at one year. 
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PROFORMA 
VISUAL OUTCOME OF PRK IN LOW TO MODERATE MYOPIA 
 
NAME OF PATIENT:   AGE:  SEX: 
 
OCCUPATION:      IP No.: 
 
DATE OF ADMISSION: 
 
DATE OF OPERATION: 
 
DATE OF DISCHARGE: 
 
HISTORY: 
 
COMPLAINTS 
 
 
History of: 
 
1. Wearing spectacles- Duration, last change of glasses 
2. Wearing contact lens- Duration, type (soft/rigid/gas permeable 
PMMA) 
3. Previous refractive surgery 
4. Disease of the eye 
5. Any allergy 
6. Previous squint surgery, RD surgery, Laser for retinal holes 
7. Pregnancy/ Lactation 
8. Social history- Occupation 
9. Medical History 
 
 
OCULAR EXAMINATION  
 
1. Uncorrected Visual Acuity- Distant Vision: Aided 
     Unaided 
        Refraction 
2. Lids and Adnexa- Chalazion, Blepharitis, Stye 
3. Palpebral fissure- Deep socket, Prominent eyes 
4. Squint, Nystagmus 
5. Conjunctiva- Scarring, Pterygium, Papillae 
6. Cornea- Size of the cornea, Clarity, Vascularisation 
7. Anterior Chamber 
8. Pupil- Size, Shape, Reaction 
9. Lens- Opacities,Subluxation 
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INVESTIGATIONS: 
 
1. Slit lamp examination- including IOP measurement 
2. Corneal Topography- irregular astigmatism  
3. Ultrasound pachymetry 
4. Indirect Ophthalmoscopy 
5. Tear film Stability 
6. WASCA aberrometry- 3rd, 4th aberrations pupil size in dark 
 
VISION    RE    LE  
 
Distant vision- unaided  
 
    with pinhole 
 
 
Refraction     - with correction 
 
AR 
 
BCVA 
 
Near vision- unaided  
 
                   With correction 
 
 
PROCEDURE 
 
 
POST OPERATIVE EVALUATION 
 
Day 0-visual acuity, refraction, slit lamp examination 
 
Day 1 
 
Day 3 
 
1 month  
 
3 months  
 
6 months 
 
1 year 
 
Remarks 
